KLP Kapitalforvaltning AS Buys New Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

KLP Kapitalforvaltning AS purchased a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 40,800 shares of the medical instruments supplier's stock, valued at approximately $780,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. American Century Companies Inc. grew its holdings in DENTSPLY SIRONA by 38.2% during the 4th quarter. American Century Companies Inc. now owns 3,873,645 shares of the medical instruments supplier's stock valued at $73,522,000 after buying an additional 1,071,604 shares in the last quarter. Quantbot Technologies LP grew its holdings in shares of DENTSPLY SIRONA by 852.6% in the fourth quarter. Quantbot Technologies LP now owns 272,849 shares of the medical instruments supplier's stock valued at $5,179,000 after purchasing an additional 244,205 shares in the last quarter. Sciencast Management LP increased its position in DENTSPLY SIRONA by 236.3% in the fourth quarter. Sciencast Management LP now owns 69,276 shares of the medical instruments supplier's stock worth $1,315,000 after purchasing an additional 48,676 shares during the last quarter. Xponance Inc. raised its stake in DENTSPLY SIRONA by 7.3% during the fourth quarter. Xponance Inc. now owns 33,034 shares of the medical instruments supplier's stock valued at $627,000 after purchasing an additional 2,235 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC purchased a new stake in DENTSPLY SIRONA during the fourth quarter valued at $299,000. Institutional investors own 95.70% of the company's stock.

Remove Ads

Insiders Place Their Bets

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction on Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Stock Down 0.3 %

DENTSPLY SIRONA stock traded down $0.04 during trading hours on Friday, reaching $13.58. The stock had a trading volume of 4,926,034 shares, compared to its average volume of 2,924,448. DENTSPLY SIRONA Inc. has a 52 week low of $12.54 and a 52 week high of $33.02. The company has a market cap of $2.70 billion, a price-to-earnings ratio of -6.56, a PEG ratio of 1.80 and a beta of 0.98. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business's 50 day moving average price is $17.14 and its 200-day moving average price is $19.76.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.71%. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.07%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on XRAY. Evercore ISI restated an "in-line" rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. StockNews.com downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a report on Friday, February 28th. Finally, Mizuho dropped their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $23.33.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.